AXON vs RKLB vs ESLT
161 measures in 16 categories, one definition each, computed from filings and market data.
AXON48.2
Axon Enterprise, Inc.
Industrials · Aerospace & Defense
$390.29 −6.45%$31.7B mkt cap
Score DNA
RKLB50.0
Rocket Lab USA, Inc.
Industrials · Aerospace & Defense
$50.84 −7.98%$30.4B mkt cap
Score DNA
ESLT65.4
Elbit Systems Ltd.
Industrials · Aerospace & Defense
$755.43 +1.86%$35.4B mkt cap
Score DNA
Price, rebased to 100 three years ago
AXON RKLB ESLT · weekly adjusted closesSmart money 8Valuation 16Profitability (TTM) 12Returns on capital 11Growth 17Margin history & stability 7Liquidity (latest quarter) 7Leverage & solvency (latest quarter) 13Efficiency 11Cash flow & earnings quality 7Dividends & buybacks 9Scores & forensic checks 15Per share 7Size (TTM) 8Price performance 9Technicals 4
● marks the highest or lowest value where that direction is plainly stronger (margins, returns, coverage, leverage); multiples and yields are left unmarked. Bars show each stock's percentile within its own industry. n/a: the measure does not apply to lenders and insurers.
Smart money
8 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Insider open-market buys, 180d | 0 | 0 | 0 |
| Insider $ bought, 180d | — | — | — |
| Congress purchases, 180d | 0 | 0 | 0 |
| Last Congress purchase | — | — | — |
| 13F net change in holders | +77 | +252 | — |
| ETFs adding shares, 30d | 1,196 | 852 | 32 |
| ETFs trimming, 30d | 902 | 528 | 28 |
| Net ETF funds, 30d | +294 | +324 | +4 |
Valuation
16 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| P/E (TTM) | 158.9x
97th
|
— | 55.5x
79th
|
| PEG (P/E ÷ 3-yr EPS CAGR) | 6.96
88th
|
— | 1.76
50th
|
| Price / sales | 9.8x
84th
|
39.6x
95th
|
4.1x
49th
|
| Price / book | 8.6x
74th
|
8.7x
75th
|
8.0x
70th
|
| Price / tangible book | 31.0x
80th
|
22.3x
71st
|
14.3x
59th
|
| Price / free cash flow | 238.0x
100th
|
— | 51.1x
80th
|
| Price / operating cash flow | 119.3x
95th
|
— | 35.1x
69th
|
| Enterprise value | $32.8B
78th
|
$28.3B
76th
|
$35.3B
80th
|
| EV / sales | 10.2x
85th
|
36.7x
95th
|
4.1x
51st
|
| EV / EBITDA | 69.5x
98th
|
— | 37.9x
88th
|
| EV / EBIT | 89.2x
95th
|
— | 47.0x
85th
|
| EV / free cash flow | 246.6x
100th
|
— | 50.9x
74th
|
| Earnings yield | 0.6%
31st
|
-0.5%
27th
|
1.8%
44th
|
| FCF yield | 0.4%
36th
|
-1.2%
25th
|
2.0%
49th
|
| Operating cash flow yield | 0.8%
33rd
|
-0.7%
22nd
|
2.8%
51st
|
| Graham number (per share) | $49.22
53rd
|
— | $165.32
92nd
|
Profitability (TTM)
12 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Gross margin | 59.4%
93rd
|
37.3%
76th
|
25.0%
46th
|
| EBITDA margin | 14.7%
64th
|
-15.9%
17th
|
10.9%
42nd
|
| Operating margin | 2.6%
28th
|
-29.1%
13th
|
9.4%
45th
|
| EBIT margin | 11.4%
62nd
|
-24.0%
17th
|
8.8%
43rd
|
| Net margin | 6.2%
51st
|
-21.5%
17th
|
7.4%
55th
|
| NOPAT margin | 2.1%
28th
|
-23.0%
13th
|
8.3%
55th
|
| FCF margin | 4.1%
43rd
|
-48.3%
11th
|
8.1%
64th
|
| Operating cash flow margin | 8.3%
47th
|
-28.9%
11th
|
11.8%
62nd
|
| R&D / revenue | 22.0%
87th
|
40.6%
94th
|
6.8%
81st
|
| SG&A / revenue | 34.8%
81st
|
25.7%
77th
|
8.8%
30th
|
| Stock comp / revenue | 19.7%
94th
|
10.6%
83rd
|
0.2%
9th
|
| Effective tax rate | 21.3%
75th
|
21.0%
45th
|
12.1%
7th
|
Returns on capital
11 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| ROE (on average equity) | 6.2%
37th
|
-7.9%
18th
|
15.3%
69th
|
| ROA | 2.9%
40th
|
-5.8%
22nd
|
4.9%
56th
|
| ROIC | 1.4%
27th
|
-13.3%
20th
|
16.5%
84th
|
| ROCE | 6.1%
40th
|
-5.0%
20th
|
10.0%
58th
|
| Return on tangible assets | 5.4%
40th
|
-6.4%
20th
|
5.8%
42nd
|
| Cash ROIC (OCF / invested capital) | 5.5%
35th
|
-16.8%
15th
|
23.5%
85th
|
| Gross profitability (GP / assets) | 25.6%
91st
|
6.8%
18th
|
15.5%
55th
|
| ROIC, 3-yr average | 8.8%
56th
|
— | 10.3%
74th
|
| ROIC, 5-yr average | 14.9%
88th
|
7.7%
44th
|
9.6%
59th
|
| ROE, 5-yr average | 10.2%
54th
|
-25.0%
12th
|
10.2%
56th
|
| Incremental ROIC | -26.3%
20th
|
0.3%
32nd
|
412.6%
98th
|
Growth
17 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Revenue growth (TTM YoY) | 34.6%
73rd
|
52.5%
84th
|
12.9%
29th
|
| Revenue growth (QoQ) | 12.0%
62nd
|
16.8%
71st
|
4.5%
25th
|
| Revenue CAGR, 3 yr | 33.1%
83rd
|
49.2%
87th
|
15.4%
59th
|
| Revenue CAGR, 5 yr | 31.9%
81st
|
76.3%
95th
|
11.5%
49th
|
| Gross profit CAGR, 3 yr | 31.8%
81st
|
109.3%
98th
|
15.1%
52nd
|
| Operating income CAGR, 3 yr | -9.1%
9th
|
— | 32.8%
79th
|
| Net income growth (TTM YoY) | -38.8%
0th
|
— | 56.8%
67th
|
| Net income CAGR, 3 yr | 26.4%
57th
|
— | 34.8%
80th
|
| EPS growth (TTM YoY) | -39.2%
0th
|
— | 52.1%
67th
|
| EPS CAGR, 3 yr | 22.8%
60th
|
— | 31.5%
73rd
|
| EPS CAGR, 5 yr | — | — | 17.6%
54th
|
| FCF growth (TTM YoY) | -24.5%
16th
|
— | 8.1%
29th
|
| FCF CAGR, 3 yr | 6.5%
18th
|
— | — |
| Operating cash flow CAGR, 3 yr | 18.8%
34th
|
— | 83.7%
93rd
|
| Book value CAGR, 3 yr | 32.7%
82nd
|
63.3%
98th
|
13.6%
61st
|
| Dividend CAGR, 3 yr | — | — | 13.0%
93rd
|
| Sustainable growth rate | 6.2%
26th
|
— | 11.8%
53rd
|
Margin history & stability
7 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Gross margin, 3-yr average | 60.0%
98th
|
30.4%
67th
|
24.3%
46th
|
| Operating margin, 3-yr average | 3.7%
28th
|
-42.0%
7th
|
7.8%
41st
|
| Net margin, 3-yr average | 12.0%
85th
|
-40.5%
13th
|
5.5%
43rd
|
| FCF margin, 3-yr average | 7.6%
61st
|
-44.8%
11th
|
6.3%
54th
|
| Revenue stability (0-1) | 0.94
73rd
|
0.94
65th
|
0.92
60th
|
| Earnings stability (0-1) | 0.61
56th
|
0.57
52nd
|
0.64
60th
|
| Margin stability (0-1) | 0.98
96th
|
0.30
11th
|
0.97
85th
|
Liquidity (latest quarter)
7 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Cash & short-term investments | $692.5M
73rd
|
$2.3B
87th
|
$962.9M
76th
|
| Net cash (− = net debt) | −$1.1B
33rd
|
$2.2B
100th
|
$110.7M
80th
|
| Working capital | $1.6B
73rd
|
$2.4B
89th
|
$2.5B
91st
|
| Current ratio | 2.15
42nd
|
5.48
89th
|
1.39
16th
|
| Quick ratio | 1.80
56th
|
4.98
89th
|
0.89
11th
|
| Cash ratio (cash + ST investments / current liabilities) | 0.50
56th
|
4.36
91st
|
0.15
11th
|
| Defensive interval (days) | 292 days
6th
|
1,816 days
85th
|
1,397 days
78th
|
Leverage & solvency (latest quarter)
13 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Total debt | $1.8B
67th
|
$133.7M
22nd
|
$852.2M
47th
|
| Debt / equity | 0.50
43rd
|
0.04
8th
|
0.19
25th
|
| Net debt / equity | 0.31
47th
|
−0.62
9th
|
−0.03
26th
|
| Debt / assets | 24.5%
51st
|
3.2%
7th
|
6.1%
18th
|
| Debt / capital | 33.3%
43rd
|
3.7%
8th
|
16.2%
25th
|
| Debt / EBITDA | 3.88
79th
|
— | 0.92
14th
|
| Net debt / EBITDA | 2.41
60th
|
— | −0.12
17th
|
| Interest coverage (EBIT / interest) | 3.2x
35th
|
−24.7x
8th
|
6.1x
56th
|
| Cash interest coverage | 2.3x
38th
|
−29.8x
0th
|
8.1x
65th
|
| Debt payback (years of OCF) | 6.9 yrs
74th
|
— | 0.8 yrs
15th
|
| Liabilities / assets | 50.9%
44th
|
16.6%
13th
|
68.2%
78th
|
| IS credit model rating | A | BBB+ | AA- |
| Implied credit spread (bps) | 150
35th
|
225
58th
|
100
22nd
|
Efficiency
11 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Asset turnover | 0.47
36th
|
0.27
18th
|
0.66
51st
|
| Fixed asset turnover | 9.43
87th
|
1.48
19th
|
4.37
46th
|
| Inventory turnover | 3.3
42nd
|
2.4
26th
|
2.1
18th
|
| Receivables turnover | 4.6
24th
|
5.7
33rd
|
2.4
0th
|
| Days sales outstanding | 79 days
76th
|
64 days
67th
|
154 days
100th
|
| Days inventory outstanding | 111 days
58th
|
150 days
74th
|
176 days
82nd
|
| Days payables outstanding | 54 days
76th
|
55 days
78th
|
90 days
85th
|
| Cash conversion cycle (days) | 136 days
62nd
|
159 days
69th
|
240 days
93rd
|
| Capex / revenue | 4.1%
60th
|
19.3%
81st
|
3.7%
55th
|
| Capex / depreciation | 1.27
57th
|
2.39
83rd
|
1.75
70th
|
| Operating expense ratio | 55.2%
83rd
|
60.7%
85th
|
15.8%
48th
|
Cash flow & earnings quality
7 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Operating cash flow / net income | 1.33
56th
|
— | 1.58
72nd
|
| FCF / net income | 0.67
31st
|
— | 1.09
62nd
|
| FCF / operating cash flow | 50.1%
16th
|
— | 68.7%
39th
|
| Capex / operating cash flow | 49.9%
84th
|
— | 31.3%
61st
|
| Accruals ratio | -1.0%
62nd
|
2.0%
85th
|
-2.9%
45th
|
| Sloan accruals ratio | -15.0%
4th
|
58.4%
100th
|
5.4%
71st
|
| Earnings quality score (0-1) | 1.00
49th
|
— | 1.00
49th
|
Scores & forensic checks
15 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| IS score | 48
44th
|
50
45th
|
65
75th
|
| IS profitability | 32
51st
|
11
16th
|
37
58th
|
| IS growth | 41
6th
|
88
96th
|
67
43rd
|
| IS value | 32
16th
|
27
4th
|
30
13th
|
| IS momentum | 70
27th
|
80
47th
|
93
80th
|
| IS risk (safety) | 100
44th
|
100
44th
|
80
29th
|
| IS quality | 69
64th
|
46
31st
|
77
93rd
|
| IS balance sheet | 61
56th
|
34
20th
|
67
73rd
|
| IS earnings quality | 74
80th
|
54
31st
|
69
67th
|
| IS cash flow | 37
44th
|
30
20th
|
64
71st
|
| Piotroski F-score (0-9) | 6
31st
|
4
15th
|
8
84th
|
| Altman Z-score | 8.4
80th
|
55.6
100th
|
3.3
33rd
|
| Beneish M-score | −2.32
66th
|
−1.50
88th
|
−2.47
40th
|
| Ohlson O-score | −7.84
51st
|
−9.25
15th
|
−7.34
62nd
|
| IS credit score | 72
55th
|
60
36th
|
82
73rd
|
Size (TTM)
8 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| Market cap | $31.7B
78th
|
$30.4B
76th
|
$35.4B
80th
|
| Revenue | $3.2B
56th
|
$769.1M
36th
|
$8.6B
78th
|
| EBITDA | $472.5M
56th
|
−$122.1M
13th
|
$930.9M
73rd
|
| Net income | $199.6M
56th
|
−$165.5M
15th
|
$637.9M
76th
|
| Free cash flow | $133.2M
58th
|
−$371.1M
7th
|
$692.8M
80th
|
| Total assets | $7.5B
73rd
|
$4.2B
51st
|
$13.9B
84th
|
| Shareholders' equity | $3.7B
73rd
|
$3.5B
71st
|
$4.4B
76th
|
| Employees | 5,100
55th
|
2,600
45th
|
21,000
80th
|
Price performance
9 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| 1 day | −6.5% | −8.0% | +1.9% |
| 1 week | −7.7% | −25.5% | +15.4% |
| 1 month | −13.9% | −25.0% | +0.9% |
| 3 months | −26.0% | −22.7% | +0.1% |
| 6 months | −3.1% | −40.0% | −13.4% |
| Year to date | −30.7% | −33.1% | +27.6% |
| 1 year | −39.5% | −26.6% | +50.5% |
| 3 years, cumulative | +77.4% | +952.6% | +257.7% |
| 5 years, cumulative | +137.2% | +245.6% | +442.7% |
Technicals
4 measures| Measure | AXON | RKLB | ESLT |
|---|---|---|---|
| RSI 14 | 32.1 | 25.4 | 62.8 |
| From 52-week high | −48.9% | −66.3% | −25.6% |
| From 52-week low | +15.1% | +35.3% | +67.0% |
| Beta | 1.44 | 2.61 | -0.23 |
InsiderStreet reports findings from filings and market data. A comparison is not a recommendation to buy or sell either stock.Every figure is computed in code · data as of 2026-10-17